Published on
Newly published research indicates that remdesivir shortens disease course in patients hospitalized with COVID-19. Data from the National Institute of Allergy and Infectious Diseases, published in the New England Journal of Medicine, show that patients who received a 10-day course of remdesivir had a reduced recovery time of 11 days, vs 15 days to recovery in patients who did not receive remdesivir. The findings were consistent with preliminary data released by the NIAID weeks ago.
Update: One Agent Shows Promise for COVID-19